We carried out a meta-analysis of the efficacy and security related to probiotic therapy for BV.
Conclusions: Probiotic regimes are protected and will exhibit a short-term and long-term helpful impact for BV therapy.
Introduction Bacterial vaginosis (BV) is likely one of the most typical ailments in girls of reproductive age [1].
The usage of probiotics for therapy may be dated again to 1907 by Metchnikoff [12], and adopted by Newman (1915) and Löser (1920) [13,14].
In distinction, probiotic remedy alone confirmed a greater profit in efficacy for BV therapy over the placebo.
Conclusions In conclusion, probiotic-only regimes are protected and will exhibit short-term and long-term helpful results for BV therapy.
